| RS2490588301 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490592102 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490592318 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS2490594673 |
MUSK
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 9, Fetal akinesia deformation sequence 1 |
| RS2490595544 |
IARS1
|
Health Risk |
Pathogenic |
— |
| RS2490595586 |
MUSK
|
Health Risk |
Likely pathogenic |
— |
| RS2490598994 |
ERCC6L2
|
Health Risk |
Likely pathogenic |
ERCC6L2-related disorder, ERCC6L2-related disorder |
| RS2490599065 |
ERCC6L2
|
Health Risk |
Pathogenic |
— |
| RS2490602769 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490602783 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Metaphyseal chondrodysplasia |
| RS2490602876 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490602916 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490602929 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490602952 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490602964 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490602971 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490603023 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490603242 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490603296 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490603538 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490603549 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS2490603615 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2490604082 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490604150 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Anauxetic dysplasia, Metaphyseal chondrodysplasia |
| RS2490604293 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490604530 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490604636 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS2490610421 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490610438 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490610455 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia type I, Citrullinemia |
| RS2490610627 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490612370 |
SURF1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2490613319 |
SURF1
|
Health Risk |
Pathogenic |
— |
| RS2490613354 |
SURF1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2490613394 |
SURF1
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2490613455 |
SURF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leigh syndrome, Mitochondrial complex IV deficiency |
| RS2490613548 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2490613607 |
SURF1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2490613666 |
SURF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leigh syndrome, Charcot-Marie-Tooth disease type 4K |
| RS2490613671 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2490613891 |
SURF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leigh syndrome, Charcot-Marie-Tooth disease type 4K |
| RS2490613924 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2490614044 |
SURF1
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2490616080 |
SURF1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2490616299 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2490616670 |
SURF1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2490616704 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2490616724 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2490616900 |
SURF1
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2490616999 |
SURF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leigh syndrome, Mitochondrial complex IV deficiency |
| RS2490617017 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2490617074 |
SURF1
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2490619353 |
SURF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leigh syndrome, Mitochondrial complex IV deficiency |
| RS2490619546 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2490620007 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2490621719 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS2490621738 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490621864 |
ASS1
|
Health Risk |
Likely pathogenic |
ASS1-related disorder, ASS1-related disorder |
| RS2490621912 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490621965 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS2490622155 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS2490623261 |
SURF1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2490623379 |
SURF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leigh syndrome, Mitochondrial complex IV deficiency |
| RS2490623421 |
SURF1
|
Health Risk |
Pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2490623707 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2490627975 |
SURF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2490628066 |
SURF1
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Leigh syndrome |
| RS2490628954 |
SURF1
|
Health Risk |
Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2490628968 |
SURF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS2490631214 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490631235 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia, Citrullinemia |
| RS2490631524 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490634930 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490641031 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS2490653678 |
COL5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490653790 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490659920 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490660155 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490664456 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490664696 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490665160 |
TMEM126B
|
Health Risk |
Pathogenic |
— |
| RS2490665880 |
COL5A1
|
Health Risk |
Likely pathogenic |
COL5A1-related disorder, COL5A1-related disorder |
| RS2490670454 |
TPM2
|
Health Risk |
Likely pathogenic |
TPM2-related disorder, TPM2-related disorder |
| RS2490678140 |
MUSK
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 9, Fetal akinesia deformation sequence 1 |
| RS2490680513 |
LAMC3
|
Health Risk |
Likely pathogenic |
— |
| RS2490682185 |
LMX1B
|
Health Risk |
Likely pathogenic |
LMX1B-related disorder, LMX1B-related disorder |
| RS2490682241 |
LMX1B
|
Health Risk |
Pathogenic |
LMX1B-related disorder, LMX1B-related disorder |
| RS2490682549 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2490682650 |
LMX1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Nail-patella syndrome, Nail-patella syndrome |
| RS2490682841 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2490682861 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2490683095 |
TPM2
|
Health Risk |
Likely pathogenic |
— |
| RS2490683549 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490683572 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490684829 |
TPM2
|
Health Risk |
Likely pathogenic |
— |
| RS2490687634 |
LMX1B
|
Health Risk |
Pathogenic |
LMX1B-related disorder, LMX1B-related disorder |
| RS2490687658 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2490688015 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2490688207 |
LMX1B
|
Health Risk |
Likely pathogenic |
Nail-patella syndrome, Nail-patella syndrome |
| RS2490689093 |
LMX1B
|
Health Risk |
Pathogenic |
Nail-patella syndrome, Nail-patella syndrome |